U.S. will keep Covid public health emergency in place at least until mid January

U.S. will keep Covid public health emergency in place at least until mid January


Secretary of Health and Human Services Xavier Becerra answers questions during a Senate Health, Education, Labor, and Pensions Committee hearing to discuss reopening schools during the coronavirus disease (COVID-19) at Capitol Hill in Washington, D.C., September 30, 2021.

Greg Nash | Pool | Reuters

The U.S. Covid public health emergency will remain in place past Jan. 11 after the federal government did not notify states or health-care provides on Friday of any intent to lift the declaration.

Health and Human Services Secretary Secretary Xavier Becerra has promised to give stakeholders 60 days notice before lifting the emergency declaration so they can prepare for a return to normal operations. In October, HHS extended the public health emergency until Jan. 11.

HHS did not provide a 60-day notice on Friday, which was the deadline to alert states and health-care providers if the federal government planned to lift the declaration on Jan. 11, according to a Health and Human Services spokesperson. Since HHS did not provide notification, the emergency will remain in place for at least another 60 days until mid January.

Public health officials are expecting another Covid surge this winter as people gather more indoors where the virus spreads easier. The future also remains uncertain as more immune evasive omicron subvariants become dominant in the U.S.

How the U.S. fares against Covid this fall and winter will help determine whether the emergency needs to be renewed again moving forward, Becerra told reporters in October.

The public health emergency, first declared in January 2020 and renewed every 90 days since, has had a vast impact on the U.S. health-care system. The declaration has dramatically expanded public health insurance through Medicaid and the Children’s Health Insurance Program. Enrollment in these programs increased 26% during the pandemic to a record of more than 89 million people as of June.

HHS has estimated that as many as 15 million people could lose Medicaid or CHIP once the programs return to normal operations.

The emergency declaration has also given hospitals and other health-care providers more flexibility in how they operate.

Correction: HHS clarified that public health emergency remains in place for at least another 60 days, which is mid January.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know
Health

Healthy Returns: FDA may add its strongest safety warning to Covid vaccines. Here’s what to know

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The Food and Drug Administration may add its strongest safety warning to Covid shots – marking another major shift in vaccine oversight.  It could also expand a […]

Read More
‘The next protein’: Fiber is shaping up to be the latest grocery obsession
Health

‘The next protein’: Fiber is shaping up to be the latest grocery obsession

Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, U.S., February 9, 2024. Brian Snyder | Reuters One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the […]

Read More
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More